Pharmaceutical Anti-Corruption Compliance Conference In Philadelphia December 11-12

more+
less-

The pharmaceutical; medical device and medical supply industry have all been hit hard by Foreign Corrupt Practices Act (FCPA) enforcement actions. Just this summer, enforcement actions were announced against Pfizer which contained several obligations, beyond the 13 point minimum best practices compliance program, that were included in its ‘Enhanced Compliance Obligations’. What are some of the specific issues that make FCPA compliance in these industries so challenging? More importantly what are some of the responses and techniques that compliance professionals can recommend that their companies implement to help protect it from, and mitigate, FCPA compliance risk? If you want to explore these questions, and others, and help get some answers I hope that you can attend next week’s Pharmaceutical Anti-Corruption Compliance Conference in Philadelphia, hosted by Hanson Wade. Rarely has there been an event so targeted to answering the compliance challenges to several related industries.

LOADING PDF: If there are any problems, click here to download the file.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Thomas Fox, Advanced Compliance Solutions | Attorney Advertising

Written by:

more+
less-

Advanced Compliance Solutions on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×
Loading...
×
×